247
Views
15
CrossRef citations to date
0
Altmetric
Esophagus

Effects of mosapride on secondary peristalsis in patients with ineffective esophageal motility

, , &
Pages 1363-1370 | Received 17 Jul 2013, Accepted 29 Aug 2013, Published online: 08 Oct 2013

References

  • Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547–52.
  • Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986;91:897–904.
  • Olsen AM, Schlegel JF. Motility disturbances caused by esophagitis. J Thorac Cardiovasc Surg 1965;50:607–12.
  • Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997;42:1859–65.
  • Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984;310:284–8.
  • Schoeman MN, Holloway RH. Stimulation and characteristics of secondary oesophageal peristalsis in normal subjects. Gut 1994;35:152–8.
  • Hwang K. Mechanism of transportation of the content of the esophagus. J Appl Physiol 1954;6:781–96.
  • Paterson WG. Neuromuscular mechanisms of esophageal responses at and proximal to a distending balloon. Am J Physiol 1991;260:G148–55.
  • Kravitz JJ, Snape WJ Jr, Cohen S. Effect of thoracic vagotomy and vagal stimulation on esophageal function. Am J Physiol 1978;234:E359–64.
  • Lang IM, Medda BK, Shaker R. Mechanisms of reflexes induced by esophageal distension. Am J Physiol Gastrointest Liver Physiol 2001;281:G1246–63.
  • Ruth M, Finizia C, Cange L, Lundell L. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2003;15:1115–21.
  • Ruth M, Hamelin B, Rohss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1998;12:35–40.
  • Cho YK, Choi MG, Han HW, Park JM, Oh JH, Jeong JJ, et al. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers. J Clin Gastroenterol 2006;40:286–92.
  • Koshino K, Adachi K, Furuta K, Ohara S, Morita T, Nakata S, et al. Effects of mosapride on esophageal functions and gastroesophageal reflux. J Gastroenterol Hepatol 2010;25:1066–71.
  • Chen CL, Liu TT, Yi CH, Orr WC. Effects of mosapride on esophageal secondary peristalsis in humans. Neurogastroenterol Motil 2011;23:606–e249.
  • Chen CL, Yi CH. Assessment of esophageal motor function using combined multichannel intraluminal impedance and manometry in healthy volunteers: A single-center study in Taiwan. J Gastroenterol Hepatol 2007;22:1039–43.
  • Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol 2004;2:230–6.
  • Itoh H, Nagano T, Takeyama M. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. Biol Pharm Bull 2001;24:1072–5.
  • Chen CL, Szczesniak MM, Cook IJ. Oesophageal bolus transit and clearance by secondary peristalsis in normal individuals. Eur J Gastroenterol Hepatol 2008;20:1129–35.
  • Makimoto N, Sakurai-Yamashita Y, Furuichi A, Kawakami S, Enjoji A, Kanematsu T, et al. In vivo assessment of acceleration of motor activity associated with acetylcholine release via 5-hydroxytryptamine4 receptor in dog intestine. Jpn J Pharmacol 2002;90:28–35.
  • Christensen J. Origin of sensation in the esophagus. Am J Physiol 1984;246:G221–5.
  • Mei N. Gastrointestinal vagal mechanoreceptors in the cat. Exp Brain Res 1970;11:502–14.
  • Moummi C, Yang DC, Gullikson GW. 5-HT4 receptor activation induces relaxation and associated cAMP generation in rat esophagus. Eur J Pharmacol 1992;216:47–52.
  • Grider JR. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 2003;307:460–7.
  • Castell DO. Medical therapy for reflux esophagitis: 1986 and beyond. Ann Intern Med 1986;104:112–14.
  • Corazziari E, Bontempo I, Anzini F. Effects of cisapride on distal esophageal motility in humans. Dig Dis Sci 1989;34:1600–5.
  • Grande L, Lacima G, Ros E, Garcia-Valdecasas JC, Fuster J, Visa J, et al. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study. Dig Dis Sci 1992;37:583–8.
  • Koutsoumbi P, Epanomeritakis E, Tsiaoussis J, Athanasakis H, Chrysos E, Zoras O, et al. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors. Am J Gastroenterol 2000;95:3388–92.
  • Holloway RH. Topographical clinical esophageal manometry: a better mousetrap or manometric overkill? Am J Gastroenterol 2000;95:2677–9.
  • Park H, Conklin JL. Neuromuscular control of esophageal peristalsis. Curr Gastroenterol Rep 1999;1:186–97.
  • Schoeman MN, Holloway RH. Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease. Gut 1995;36:499–504.
  • Orr WC, Robinson MG, Johnson LF. Acid clearance during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci 1981;26:423–7.
  • Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995;108:83–91.
  • Basilisco G, Carola F, Vanoli M, Bianchi P, Barbera R. Oesophageal acid clearance in patients with systemic sclerosis: effect of body position. Eur J Gastroenterol Hepatol 1996;8:205–9.
  • Fornari F, Blondeau K, Durand L, Rey E, Diaz-Rubio M, De Meyer A, et al. Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;26:1345–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.